Feature | Business | August 16, 2017| Dave Fornell

CMS to Cancel Mandatory Cardiac Bundled Payments and Cardiac Rehabilitation Payment Model

CMS says proposed rule to offer greater flexibility and choice for hospitals in orthopedic care for Medicare beneficiaries

CMS considers eliminating cardiac bundled payments.

August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number of mandatory geographic areas participating in the Center for Medicare and Medicaid Innovation’s (Innovation Center) Comprehensive Care for Joint Replacement (CJR) model from 67 to 34. In addition, CMS proposes to allow CJR participants in the 33 remaining areas to participate on a voluntary basis. In this rule, CMS also proposes to make participation in the CJR model voluntary for all low-volume and rural hospitals in all of the CJR geographic areas.

CMS also is proposing through this rule to cancel the Episode Payment Models (EPMs) and the cardiac rehabilitation (CR) incentive payment model, which were scheduled to begin on Jan. 1, 2018. Eliminating these models would give CMS greater flexibility to design and test innovations that will improve quality and care coordination across the in-patient and post-acute-care spectrum. This includes care to patients who receive treatment for heart attacks, heart surgery to bypass blocked coronary arteries, or cardiac rehabilitation following a heart attack or heart surgery.

CMS has delayed these bundled payment initiatives twice since President Trump appointed Health and Human Services (HHS) Secretary Tom Price, M.D., and CMS Administrator Seema Verma, MPH. Both have been critics of mandatory bundled payments. Cardiac bundled payments were supposed to begin July 1, 2017 and were pushed back to Jan. 1, 2018.

The original intent of the bundled payments was to move away from traditional fee-for-service reimbursement to a fee-for-value model. The idea was to force hospitals to become more efficient in order to reduce their healthcare costs. The cardiac EPMs includes patients with myocardial infarction who undergo percutaneous coronary intervention (PCI) with or without stenting, and coronary bypass graft surgery (CABG). 

“Changing the scope of these models allows CMS to test and evaluate improvements in care processes that will improve quality, reduce costs and ease burdens on hospitals,” said CMS Administrator Seema Verma. “Stakeholders have asked for more input on the design of these models. These changes make this possible and give CMS maximum flexibility to test other episode-based models that will bring about innovation and provide better care for Medicare beneficiaries.”

Moving forward, CMS expects to increase opportunities for providers to participate in voluntary initiatives rather than large mandatory episode payment model efforts. The changes in the proposed rule would allow the agency to engage providers in future voluntary efforts, including additional voluntary episode-based payment models.  

The EPMs and the CR incentive models were designed as mandatory payment models and implemented via notice and comment rulemaking to test the effects of bundling cardiac and orthopedic care beginning in 2018. They were established by the Innovation Center under the authority of section 1115A of the Social Security Act (the Act).

“The American College of Cardiology will continue to work with CMS on opportunities for clinicians to participate meaningfully in Advanced Alternative Payment Models,” said American College of Cardiology (ACC) President Mary Norine Walsh, M.D., FACC. "As we move from volume-based care to value-based care, the path forward is challenging and we must work together to find solutions.”

The Society for Cardiovascular Angiography and Interventions (SCAI) has been closely watching developments regarding a proposed HHS/CMS rule. In April, SCAI expressed concerns and recommended revisions to the program that was slated to go into effect January 1, 2018, in a letter to Secretary Price. 

In the letter, the society expressing concerns over bundled payments and applauded the delay of implementing these payment models. SCAI has advocated for a purely voluntary program because many hospitals are not yet prepared to meet the rigors of the program. The society also listed other concerns:

• CMS should recognize the ACC/NCDR as a voluntary option so a hospital can make risk-adjustments for the AMI bundled payment program.
• Add the AMI CPT Code 92941 to the inpatient-only list so patients are not relegated to outpatient/observation status. SCAI also asked CMS to exclude any non-STEMI PCI cases reported using code 9294 from the bundled payment program.
• Exclude cardiogenic shock and out-of-hospital cardiac arrest patients from the program.
• Exempt patients from the program that have MI as a secondary diagnosis.
• Narrow the 90-day bundled payment period down to 30 days.
• Remove multi-vessel disease patients from bundled payments because they may not receive optimal care with additional stents because of fears of additional cost.
• CMS should consider and track the use of bare metal vs. drug-eluting stents in the program, as hospitals may opt for the less expensive, bare metal stents and might end up poor long term outcomes.

 

At the Summer 2017 National Governors Association Meeting in July, Verma said CMS is starting a major deregulation initiative. She said the move is designed to make it easier for healthcare providers and states to spend more time and resources focusing on delivering care, and less time and resources trying to comply with complex regulations that do not meaningfully improve care, quality or safety. Read comments made by Verma and Price at the July meeting.

For more information on the Comprehensive Care for Joint Replacement Model, please visit: https://innovation.cms.gov/initiatives/cjr

For more information on the EPM and CR models proposed for rescission, please visit: https://innovation.cms.gov/initiatives/epm

The proposed rule (CMS-5524-P) can be downloaded from the Federal Register at: www.federalregister.gov/public-inspection. Public comments are due by Oct.16 at 11:59 pm EST.

 

Related Bundled Payment Content:

HHS Finalizes Bundled Payments for Cardiac, Orthopedic Care

Preparing for Cardiology Bundled Payments in 2017

VIDEO: MACRA's Impact on Cardiology — Interview with Kim Williams, M.D.

HHS Sets Clear Goals, Timeline for Shifting Reimbursements From Volume to Value

Radiology is Not Business as Usual

Federal Requirements for Clinical Decision Support for Imaging

Related Content

DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery| September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Overlay Init